Cat Allergy in Humans Market to Reach Valuation of USD 5.46 Billion by 2028 – Increasing Adoption Of Cats Drives the Market

Vantage Market Research

Jul 20, 2022

In terms of revenue, the Global Cat Allergy in Humans Market is expected to reach USD 5.46 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.70% from 2022 to 2028.

The increasing adoption of cats is anticipated to augment the growth of the Cat Allergy in Humans Market during the forecast period. In addition, the rise in the incidence of allergic rhinitis and the expansion of government-funded healthcare programs to promote awareness of cat litter allergy in humans are driving the growth of the Cat Allergy in Humans Market.

Key Highlights from Report:

  • An Air Purifier Type sub-segment is accounted for the substantial growth of the Cat Allergy in Humans Market in 2021. An air purifier is used to minimize contaminants from the air, which helps the market's segmental growth.
  • The Allergy Treatment sub-segment, from the Application segment, held potential growth in the Cat Allergy in Humans Market in 2021. The Allergy Treatment is used to reduce sensitivity over time. The medications used include leukotriene modifiers, decongestants, immunotherapy (shot), antihistamines, and inhaled steroids or nasal sprays.

  • Asia Pacific is expected to grow at the fastest Compound Annual Growth Rate (CAGR) during the forecast period. An increase in home construction, automotive assembling, export of woodworking tools, and establishment of new manufacturing units in countries such as Vietnam and the Philippines are also anticipated to support the regional growth of the market.

Market Dynamics:

Dead flakes of skin exposure trigger the main reason for pet allergy. Animals can cause pet allergy if they have fur on the body, but mainly pet allergy is associated with cats and dogs. There are many symptoms caused by inflammation of the nasal passage. Such as runny nose, itchy nose, sneezing, nasal congestion, cough, and swollen blue-colored skin under the eyes. These are some signs and symptoms experienced by humans.

It is estimated that globally around 10-20% of human adults are allergic to cats (a figure that has been increasing), that cat allergy among humans is second only to house dust mite as a cause of indoor respiratory allergy, and that around 20-30% of patients with respiratory allergy are allergic to cats.

A 2008 survey by the World Society for the Protection of Animals (WSPA) compared estimated owned pet dog and cat populations in 79 countries worldwide and found that in 26 (33%), the cat population was higher than the dog population. The data from WSPA also suggested that cat populations globally were growing faster than dog populations. Similarly, a Growth from Knowledge Survey published in 2016 found that in 8/22 (36%) countries surveyed, and there were a higher number of cat-owning households than dog-owning households.

North America held the most significant shares in 2021. The US had the largest share in this region for the Cat Allergy in Humans Market, owing to the high number of cat allergies reported in this region. In addition, technological development related to testing allergies is also expected to support the growth of the Cat Allergy in Humans Market.

Cat Allergy in Humans Market Size, Share & Trends Analysis Report by Treatment (Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors), by Application (Allergy Treatment, Allergy Prevention), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)